Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2020-06-30 Proxy Solicitation & In…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is described as an 'Amendment No. 1' to a Definitive Proxy Statement filed previously. It specifically states it is an amendment to replace the sample proxy card included in the Definitive Proxy Statement. The document does not contain financial data or detailed report content but is related to proxy solicitation materials for a shareholder meeting. According to the filing definitions, proxy solicitation materials and related amendments fall under 'Proxy Solicitation & Information Statement (PSI)'. The document length is 2858 characters, which is short and consistent with an amendment or additional proxy materials rather than a full report. Therefore, the correct classification is PSI.
2020-06-30 English
DEF 14A
Proxy Solicitation & Information Statement
2020-06-26 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the calendar year 2019. It references Rule 13p-1 under the Securities Exchange Act and includes a conflict minerals disclosure and report. The document length is 3599 characters, which is relatively short and primarily serves as a disclosure report rather than a full financial or annual report. Form SD filings are specialized disclosures distinct from annual reports, earnings releases, or other financial filings. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory disclosure that does not fit into other specific categories like 10-K or IR.
2020-06-01 English
FORM 4
Director's Dealing
2020-05-14 English
10-Q
Interim / Quarterly Report Q1 2020
2020-05-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 11, 2020, reporting the results of operations for the first fiscal quarter ended March 31, 2020. It specifically mentions an attached earnings press release (Exhibit 99.1) and states that the information is not deemed filed for certain regulatory purposes. The content is typical of an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). The document length is 3543 characters, which is relatively short and consistent with an earnings release rather than a full interim report. Therefore, the appropriate classification is Earnings Release (ER).
2020-05-11 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.